-
Mashup Score: 1Leukocyte Count in Robot vs Video Thoracic Surgery As Surgical Stress Indicator - Oncology Nurse Advisor - 6 day(s) ago
Researchers analyzed the surgical stress response and tissue trauma in patients with NSCLC after robot-assisted and video-assisted procedures using leukocyte count as a surrogate measure.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 31KRAS in NSCLC: Beyond G12C | IASLC - 9 day(s) ago
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses KRAS mutant non-small cell lung cancer, focusing on non-G12C mutations. KRAS mutations …
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet-
KRAS mutations are common in #lungcancer, & while there are multiple approved/active KRAS inhibitors, they are specifically for the G12C mutation. @StephenVLiu discusses KRAS mutant #NSCLC w/focus on non-G12C mutations w/Dr. Veluswamy & @MarianaBrandao0: https://t.co/iI5ORV5u8l https://t.co/RPxBJbqO5a
-
-
Mashup Score: 1
Neoadjuvant chemoimmunotherapy improves outcomes over chemotherapy alone in patients with early-stage NSCLC, according to a meta-analysis.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Alectinib Outperforms Chemo in ALK+ NSCLC - 19 day(s) ago
Adjuvant alectinib improved disease-free survival when compared to platinum-based chemotherapy in patients with ALK-positive non-small cell lung cancer in a phase 3 trial.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2BMI Did Not Impact Chemoimmunotherapy Outcomes in Advanced NSCLC - 28 day(s) ago
Researchers found no association between BMI and outcomes of front-line chemoimmunotherapy in patients with advanced NSCLC.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Results of a meta-analysis suggest that neoadjuvant chemoimmunotherapy is superior to neoadjuvant chemotherapy for patients with non-small cell lung cancer.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2New Guidelines for Stage IV NSCLC Without Driver Alterations - 1 month(s) ago
ASCO has released updated guidelines for the treatment of stage IV NSCLC without driver alterations.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1New Guidelines for Stage IV NSCLC Without Driver Alterations - Oncology Nurse Advisor - 1 month(s) ago
ASCO has released updated guidelines for the treatment of stage IV NSCLC without driver alterations.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Older adults with PD-L1+ NSCLC may fare better if they receive immunotherapy rather than chemoimmunotherapy, data suggest.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Adding Chemo to Immunotherapy Provides No Benefit in Older NSCLC Patients - Oncology Nurse Advisor - 2 month(s) ago
Older adults with PD-L1+ NSCLC may fare better if they receive immunotherapy rather than chemoimmunotherapy, data suggest.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
Researchers assessed postoperative leukocyte count as an indicator of surgical stress response in a recent retrospective analysis encompassing patients with non-small cell #lungcancer who underwent RATS or VATS. https://t.co/H8c6oO0Qgc #NSCLC